Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Inventurus Knowledge IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2006 Industry: IT - Software Listed Page

Profile
Issue Size --
Profile
Price Range 1265  to  1329 per share
Profile
Min Investment ₹1329
Profile
Lot Size 1
Profile
Face Value ₹1
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a healthcare technology company that assists healthcare providers by managing administrative tasks and streamlining operations. The company offers a wide range of services, including clinical support, medical documentation management, and virtual medical scribing, helping doctors and healthcare organizations reduce their administrative burden. IKS Health provides a platform that supports both outpatient and inpatient care. Outpatient services, or ambulatory care, involve medical treatments that do not require hospitalization, while inpatient care refers to treatments for patients admitted to a facility for an extended stay. Read More

Basic Info

Face Value 1 per share

Price 1265  to  1329 per share

P/E (x) 45.5

Sales( Cr.) 2664

PAT( Cr.) 486

EPS 29.2

Draft Prospectus --

Exchange BSE-NSE

Promoter

Company Promoters

Sachin Gupta Rekha Jhunjhunwala Aryaman Jhunjhunwala Discretionary Trust Aryavir Jhunjhunwala Discretionary Trust

Pre Issue Share Holding 100%

Post Issue Share Holding 56.61%

Listing Details:

Listing Price: 1856

Listing Gain: 28.39%

Current Price: 1675.6

Gain On Issue: 1675.6 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Dec 12, 2024
Closing Date Dec 16, 2024
Allotment Dec 17, 2024
Refund Dec 18, 2024
Delivery of Shares Dec 18, 2024
Listing Date Dec 19, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 11 14,619
Retail (Max) 13 143 190,047
S-HNI (Min) 14 154 204,666
S-HNI (Max) 68 748 994,092
B-HNI (Min) 69 759 1,008,711

Objective of the Issue

The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.

Issue

Category Nos Bid Bid (x)
QIB 14096633 1136752485 80.6x
NII 2819327 65549353 23.3x
Retail 1879551 27347467 14.5x
EMP 0 0 0x
Total 18795510 990147467 52.7x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Inventurus Knowledge Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 191 291 351 397 503 529 553 764 1031 1818 2664
Other Income 0 1 3 12 23 32 16 21 29 40 40
Total Income 191 292 354 409 527 561 569 784 1060 1858 2704
Total Expenditure 164 232 305 352 393 368 348 466 639 1297 1894
Operating Profit 27 60 49 57 134 192 221 319 421 561 810
Interest 9 9 7 6 5 7 8 7 6 61 91
Depreciation 6 10 16 28 33 41 30 23 25 59 113
Exceptional Income / Expenses 0 0 0 0 0 0 0 -20 -31 0 0
Profit Before Tax 13 41 26 22 97 145 183 269 359 442 606
Provision for Tax 2 2 3 4 4 7 17 36 54 71 120
Profit After Tax 11 39 23 18 93 137 165 233 305 370 486
Adjustments -0 -0 -0 0 0 0 0 0 0 0 0
Profit After Adjustments 11 39 23 18 93 137 165 233 305 370 486
Adjusted Earnings Per Share 0.7 2.4 1.4 1.1 5.8 8.4 10.1 13.7 18.1 21.9 28.6

Inventurus Knowledge Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds -17 25 54 82 200 283 457 647 829 1158 1790
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 37 56 23 10 1 0 0 0 0 812 509
Other Non-Current Liabilities 1 2 4 -2 -11 22 9 -19 -50 92 86
Total Current Liabilities 59 67 80 90 50 81 59 83 115 881 651
Total Liabilities 80 150 161 181 240 386 524 711 894 2943 3036
Fixed Assets 17 34 43 80 52 98 87 76 59 1833 1790
Other Non-Current Assets 20 43 61 12 12 55 93 174 137 213 462
Total Current Assets 44 73 56 88 175 233 345 461 698 898 784
Total Assets 80 150 161 181 240 386 524 711 894 2943 3036

Inventurus Knowledge Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 3 15 6 6 38 82 53 146 124 -23
Cash Flow from Operating Activities 18 53 45 45 97 163 175 233 288 210 318
Cash Flow from Investing Activities -22 -39 -35 -29 -13 -80 -166 -82 -156 -1141 244
Cash Flow from Financing Activities 5 -2 -18 -16 -52 -41 -37 -59 -152 780 -389
Net Cash Inflow / Outflow 1 12 -9 -0 32 42 -27 92 -20 -151 173
Closing Cash & Cash Equivalent 3 15 6 6 38 82 53 146 124 -23 146

Inventurus Knowledge Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.68 2.39 1.4 1.15 5.77 8.45 10.1 13.72 18.13 21.9 28.55
CEPS(Rs) 1.06 3.02 2.38 2.9 7.81 10.94 11.95 15.1 19.59 25.35 35.17
DPS(Rs) 0 0 0 0 0 1.19 1.19 5.4 10 10 0
Book NAV/Share(Rs) -1.09 1.55 3.27 4.94 11.82 16.91 27.35 37.66 48.94 67.66 102.96
Core EBITDA Margin(%) 14.01 20.27 13.11 11.29 22.01 30.35 37.01 39.01 38.01 28.67 28.91
EBIT Margin(%) 11.06 16.97 9.29 7.2 20.15 28.72 34.45 36.1 35.43 27.66 26.19
Pre Tax Margin(%) 6.54 14 7.42 5.57 19.24 27.35 33.06 35.16 34.84 24.3 22.76
PAT Margin (%) 5.6 13.43 6.65 4.65 18.51 25.99 29.93 30.51 29.6 20.38 18.25
Cash Profit Margin (%) 8.66 17 11.3 11.74 25.04 33.64 35.42 33.56 31.98 23.6 22.47
ROA(%) 13.31 33.91 15 10.79 44.24 43.89 36.34 37.73 38.06 19.31 16.26
ROE(%) 0 929.34 58.45 27.57 68.97 59.01 45.74 42.85 41.72 37.63 33.55
ROCE(%) 36.17 60.44 29.33 22.73 60.07 62.42 51.44 49.95 49.52 31.77 28.65
Receivable days 71.51 53.27 46 45.45 44.61 48.18 49.37 40.74 45.34 52.46 61.24
Inventory Days 0 0 0 0 0 0 0 0 0 0.15 0
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 0 0 0 0 0 0 0 0 0 0 53.41
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 14.81
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.42 0.25 0.19 0.14 -0.07 -0.22 -0.39 -0.43 -0.49 0.48 9.95
EV/Core EBITDA(x) 2.96 1.22 1.33 0.96 -0.25 -0.59 -0.98 -1.04 -1.2 1.54 32.71
Net Sales Growth(%) 0 52.33 20.41 13.08 26.91 5.08 4.45 38.2 35.05 76.28 46.54
EBIT Growth(%) 0 133.61 -34.09 -12.34 255.11 49.8 25.28 44.82 32.55 37.59 38.78
PAT Growth(%) 0 265.06 -40.33 -20.98 405.05 47.55 20.31 40.87 31.02 21.38 31.2
EPS Growth(%) 0 248.98 -41.29 -18.12 403.05 46.35 19.5 35.92 32.1 20.77 30.41
Debt/Equity(x) -4.41 3.13 1.15 0.66 0.02 0 0 0 0 1.03 0.42
Current Ratio(x) 0.74 1.09 0.7 0.98 3.52 2.88 5.86 5.56 6.07 1.02 1.2
Quick Ratio(x) 0.74 1.09 0.7 0.98 3.52 2.88 5.86 5.56 6.07 1.02 1.2
Interest Cover(x) 2.45 5.72 4.98 4.42 22.22 20.97 24.78 38.54 60.37 8.23 7.63
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0.03

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 47% 52% 38% 30%
Operating Profit CAGR 44% 36% 33% 41%
PAT CAGR 31% 28% 29% 46%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 11% NA% NA% NA%
ROE Average 34% 38% 40% 122%
ROCE Average 29% 37% 42% 44%

Company Contact Information

Inventurus Knowledge Solutions Ltd.

Building No. 5 & 6, Unit No. 801, 8th Floor Mindspace S E Z, Thane Belapur Road Airoli, Navi Mumbai

IPO Lead Manager(s)

Inventurus Knowledge Solutions Ltd.

ICICI Securities Ltd

Jefferies India Pvt Ltd.

JM Financial Ltd.

JP Morgan India Pvt Ltd

Nomura Financial Advisory & Securities (India) Pvt Ltd.

Registrar Info

Inventurus Knowledge Solutions Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!